Arzeda Company
Arzeda develops enzyme design technology to create entirely novel designer cell factories capable of industry-scale chemical production.
Investors
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
Early Drug Development
Investors Number:
13.0
Last Funding Date:
2022-03-29
Technology:
Biotechnology, Information Services, Information Technology, Manufacturing
Founded Date:
2008-01-01
Headquarters:
Seattle, Washington, United States
Total Funding:
51447828.0
Last Funding Type:
Series B
Employee Number:
11-50